Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MAR-001 by Marea Therapeutics for Hypertriglyceridemia: Likelihood of Approval
MAR-001 is under clinical development by Marea Therapeutics and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II...
Data Insights
MAR-001 by Marea Therapeutics for Hypertriglyceridemia: Likelihood of Approval
MAR-001 is under clinical development by Marea Therapeutics and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II...